default author photo

Ingrid Murillo Jelsbak

Biofabri

SCHOLARLY PAPERS

2

DOWNLOADS

240

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Live-Attenuated M. Tuberculosis Vaccine, MTBVAC, in Adults with or Without M. Tuberculosis Sensitization: A Phase 1b/2a Randomized, Controlled, Double-Blind, Dose-Escalation Trial

Number of pages: 29 Posted: 02 Oct 2023
University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, Stellenbosch University, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, Biofabri, Biofabri, Biofabri, Biofabri, University of Zaragoza, University of Zaragoza, International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative and University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative
Downloads 124 (580,653)

Abstract:

Loading...

tuberculosis, MTBVAC, Vaccine, safety, immunogenicity

2.

Safety, Reactogenicity, and Immunogenicity of Mtbvac in Infants: A Phase 2a Randomized, Double-Blind, Dose-Defining Trial in a Tb Endemic Setting

Number of pages: 22 Posted: 31 May 2024
University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, Biofabri, Biofabri, Mukherjee Consultants, Biofabri, Biofabri, Biofabri, Biofabri, University of Zaragoza, University of Zaragoza, University of Zaragoza, University of Zaragoza, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative and University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative
Downloads 116 (613,149)

Abstract:

Loading...

tuberculosis, newborns, vaccine, BCG, MTBVAC